Body Mass Index in 1.2 Million Adolescents and Risk for End-Stage Renal Disease

被引:222
|
作者
Vivante, Asaf [1 ,2 ]
Golan, Eliezer [2 ,3 ]
Tzur, Dorit
Leiba, Adi [2 ]
Tirosh, Amir [7 ]
Skorecki, Karl [4 ,5 ]
Calderon-Margalit, Ronit [6 ]
机构
[1] Edmond & Lily Safra Childrens Hosp, Israeli Def Forces Med Corps, Chaim Sheba Med Ctr, Dept Pediat,Talpiot Med Leadership Program, IL-52621 Tel Hashomer, Israel
[2] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
[3] Israel Renal Registry, Bristol, Avon, England
[4] Technion Israel Inst Technol, Rappaport Fac Med, Dept Nephrol, Haifa, Israel
[5] Technion Israel Inst Technol, Res Inst, Haifa, Israel
[6] Hebrew Univ Jerusalem, Hadassah Braun Sch Publ Hlth, Jerusalem, Israel
[7] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA
关键词
OBESITY-RELATED GLOMERULOPATHY; US CHILDREN; KIDNEY-DISEASE; UNITED-STATES; FOLLOW-UP; PREVALENCE; OVERWEIGHT; POPULATION; PROTEINURIA; ASSOCIATION;
D O I
10.1001/2013.jamainternmed.85
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The relationship between adolescent body mass index (BMI) and future risk for end-stage renal disease (ESRD) is not fully understood, nor is it known the extent to which this association is limited to diabetic ESRD. We evaluated the association between BMI in adolescence and the risk for all-cause, diabetic, and nondiabetic ESRD. Methods: Medical data about 1 194 704 adolescents aged 17 years who had been examined for fitness for military service between January 1, 1967, and December 31, 1997, were linked to the Israeli ESRD registry in this nationwide population-based retrospective cohort study. Incident cases of treated ESRD between January 1, 1980, and May 31, 2010, were included. Cox proportional hazards models were used to estimate the hazard ratio (HR) for treated ESRD among study participants for their BMI at age 17 years, defined in accord with the US Centers for Disease Control and Prevention BMI for age and sex classification. Results: During 30 478 675 follow-up person-years (mean [SD], 25.51 [8.77] person-years), 874 participants (713 male and 161 female) developed treated ESRD, for an overall incidence rate of 2.87 cases per 100 000 person-years. Compared with adolescents of normal weight, overweight adolescents (85th to 95th percentiles of BMI) and obese adolescents (>= 95th percentile of BMI) had an increased future risk for treated ESRD, with incidence rates of 6.08 and 13.40 cases per 100 000 person-years, respectively. In a multivariate model adjusted for sex, country of origin, systolic blood pressure, and period of enrollment in the study, overweight was associated with an HR of 3.00 (95% CI, 2.50-3.60) and obesity with an HR of 6.89 (95% CI, 5.52-8.59) for all-cause treated ESRD. Overweight (HR, 5.96; 95% CI, 4.41-8.06) and obesity (HR, 19.37; 95% CI, 14.13-26.55) were strong and independent risk factors for diabetic ESRD. Positive associations of overweight (HR, 2.17; 95% CI, 1.71-2.74) and obesity (HR, 3.41; 95% CI, 2.42-4.79) with nondiabetic ESRD were also documented. Conclusions: Overweight and obesity in adolescents were associated with significantly increased risk for all-cause treated ESRD during a 25-year period. Elevated BMI constitutes a substantial risk factor for diabetic and nondiabetic ESRD.
引用
收藏
页码:1644 / 1650
页数:7
相关论文
共 50 条
  • [1] Impact of Extremes of Body Mass Index (BMI) in End-Stage Renal Disease (ESRD) Patients
    Rabbani, Rizwan
    Noel, Edva
    Boyle, Suzanne
    Khan, Waqas Ahmad
    Pronovost, Paul
    Gillespie, Avrum
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
  • [2] Proteinuria and decreased body mass index as a significant risk factor in developing end-stage renal disease
    Kunitoshi Iseki
    Kaori Tokashiki
    Chiho Iseki
    Kentaro Kohagura
    Kozen Kinjo
    Shuichi Takishita
    Clinical and Experimental Nephrology, 2008, 12 : 363 - 369
  • [3] Proteinuria and decreased body mass index as a significant risk factor in developing end-stage renal disease
    Iseki, Kunitoshi
    Tokashiki, Kaori
    Iseki, Chiho
    Kohagura, Kentaro
    Kinjo, Kozen
    Takishita, Shuichi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2008, 12 (05) : 363 - 369
  • [4] Persistent Asymptomatic Isolated Microscopic Hematuria in Israeli Adolescents and Young Adults and Risk for End-Stage Renal Disease
    Vivante, Asaf
    Afek, Arnon
    Frenkel-Nir, Yael
    Tzur, Dorit
    Farfel, Alon
    Golan, Eliezer
    Chaiter, Yoram
    Shohat, Tamy
    Skorecki, Karl
    Calderon-Margalit, Ronit
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (07): : 729 - 736
  • [5] The Protective Role of Adiponectin for Lipoproteins in End-Stage Renal Disease Patients: Relationship with Diabetes and Body Mass Index
    Coimbra, Susana
    Reis, Flavio
    Nunes, Sara
    Viana, Sofia
    Valente, Maria Joao
    Rocha, Susana
    Catarino, Cristina
    Rocha-Pereira, Petronila
    Bronze-da-Rocha, Elsa
    Sameiro-Faria, Maria
    Oliveira, Jose Gerardo
    Madureira, Jose
    Fernandes, Joao Carlos
    Miranda, Vasco
    Belo, Luis
    Santos-Silva, Alice
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2019, 2019
  • [6] Homelessness and Risk of End-stage Renal Disease
    Maziarz, Marlena
    Chertow, Glenn M.
    Himmeffarb, Jonathan
    Hall, Yoshio N.
    JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED, 2014, 25 (03) : 1231 - 1244
  • [7] Body Mass Index and Kidney Disease-Related Mortality in Midlife: A Nationwide Cohort of 2.3 Million Adolescents
    Twig, Gilad
    Vivante, Asaf
    Bader, Tarif
    Derazne, Estela
    Tsur, Avishai M.
    Levi, Moran
    Goldberger, Nehama
    Leiba, Adi
    Kark, Jeremy D.
    OBESITY, 2018, 26 (04) : 776 - 781
  • [8] Obesity, metabolic health, and the risk of end-stage renal disease
    Panwar, Bhupesh
    Hanks, Lynae J.
    Tanner, Rikki M.
    Muntner, Paul
    Kramer, Holly
    McClellan, William M.
    Warnock, David G.
    Judd, Suzanne E.
    Gutierrez, Orlando M.
    KIDNEY INTERNATIONAL, 2015, 87 (06) : 1216 - 1222
  • [9] Atopic Dermatitis and the Risk of Infection in End-Stage Renal Disease
    Momin, Rushan I.
    Baer, Stephanie L.
    Waller, Jennifer L.
    Young, Lufei
    Tran, Sarah
    Taskar, Varsha
    Bollag, Wendy B.
    MEDICINA-LITHUANIA, 2023, 59 (12):
  • [10] White/Black Racial Differences in Risk of End-stage Renal Disease and Death
    Choi, Andy I.
    Rodriguez, Rudolph A.
    Bacchetti, Peter
    Bertenthal, Daniel
    Hernandez, German T.
    O'Hare, Ann M.
    AMERICAN JOURNAL OF MEDICINE, 2009, 122 (07) : 672 - 678